Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Insulin Resistance × Clear all

Status

Completed 88 Unknown 27 Recruiting 21 Terminated 14 Withdrawn 8 Not yet recruiting 4 Active not recruiting 4 Enrolling by invitation 3 Suspended 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 45 Breast Neoplasms 44 Prostatic Neoplasms 27 Colorectal Neoplasms 26 Glioblastoma 20 Carcinoma, Non-Small-Cell Lung 19 Leukemia, Myeloid, Acute 18 Melanoma 16 Brain Neoplasms 16 Neoplasm Metastasis 15 Lung Neoplasms 15 Pancreatic Neoplasms 14 Ovarian Neoplasms 14 Glioma 14 Stomach Neoplasms 13 Carcinoma, Hepatocellular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Triple Negative Breast Neoplasms 10 Myelodysplastic Syndromes 10 Multiple Myeloma 9 Lymphoma 9 Head and Neck Neoplasms 9 Carcinoma, Renal Cell 9 Leukemia 7 Hematologic Neoplasms 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Lymphoma, Large B-Cell, Diffuse 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03652987 2021-05-25

EMDPCOS

St George's, University of London

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡